Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland

Swiss Medical Weekly

Volumn 144, Issue , 2014, Pages

  Keitel, Kristina ^a   Alcoba, Gabriel ^b   Lacroix, Laurence ^b   Manzano, Sergio ^b   Galetto Lacour, Annick ^b   Gervaix, Alain ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Community acquired pneumonia; Costs; Pneumococcal vaccines; Pneumonia

Indexed keywords

ANTITUSSIVE AGENT; DECONGESTIVE AGENT;

ADOLESCENT; ARTICLE; CHILD; CHILD HEALTH CARE; CHILDHOOD DISEASE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COST OF ILLNESS; DRUG COST; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HOSPITAL COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POPULATION RESEARCH; PROSPECTIVE STUDY; SWITZERLAND; AMBULATORY CARE; COMMUNITY ACQUIRED INFECTION; ECONOMICS; HEALTH CARE COST; HEALTH CARE PLANNING; HOSPITALIZATION; PNEUMONIA; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; COST OF ILLNESS; DIRECT SERVICE COSTS; DRUG COSTS; FEMALE; HEALTH RESOURCES; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INFANT; MALE; PNEUMONIA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWITZERLAND;

EID: 84899744092     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2014.13925     Document Type: Article

References (29)

1. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408-16. PMCID: 2647437. (Pubitemid 351694322)
2. British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood. Thorax. 2002;57 Suppl 1:i1-24. PMCID: 1765993.
3. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19(3):187-95. (Pubitemid 30167436)
4. Senstad AC, Suren P, Brauteset L, Eriksson JR, Hoiby EA, Wathne KO. Community-acquired pneumonia (CAP) in children in Oslo, Norway. Acta Paediatr. 2009;98(2):332-6.
5. Don M, Fasoli L, Paldanius M, Vainionpaa R, Kleemola M, Raty R, et al. Aetiology of community-acquired pneumonia: serological results of a paediatric survey. Scand J Infect Dis. 2005;37(11-12):806-12.
6. Juven T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19(4):293-8. (Pubitemid 30213066)
7. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113(4):701-7. (Pubitemid 38437371)
8. Cevey-Macherel M, Galetto-Lacour A, Gervaix A, Siegrist CA, Bille J, Bescher-Ninet B, et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr. 2009;168(12):1429-36.
9. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007. MMWR Morb Mortal Wkly Rep. 59(9):253-7.
10. De Graeve D, Beutels P. Economic aspects of pneumococcal pneumonia: a review of the literature. Pharmacoeconomics. 2004;22(11):719-40. (Pubitemid 38998497)
11. Jacob C, Mittendorf T, Graf von der Schulenburg JM. [Costs of illness and health-related quality of life for community-acquired pneumonia - a systematic review]. Pneumologie. 2011;65(8):498-502.
12. Hospitals FoS. REKOLE® - comptabilité de gestion à l'hôpital. 2008 [updated 2008 09/16/2011; cited]; 2008: Available from: http://www.hplus.ch/fr/gestion/comptabilite-des-hopitaux/rekoleR-le-livre/?type= orig.
13. Wages and income from employment. Lake Geneva Region. Swiss Federal Statistical Office. 2010. Available from: http://www.bfs.admin.ch/bfs/portal/en/ index/themen/03/04/blank/data/01/06-02.html.
14. Hahn, G. J. and Meeker, W. Q. (1991), Statistical Intervals: A Guide for Practitioners, New York: John Wiley & Sons.
15. Pappas DE, Hendley JO. The common cold and decongestant therapy. Pediatr Rev. 2011;32(2):47-54; quiz 5.
16. Geneva canton regional demographic data. Swiss Federal Statistical Office. 20009. Available from: http://www.bfs.admin.ch/bfs/portal/en/index/ regionen/regionalportraets/genf/blank/kennzahlen.html.
17. Ess SM, Schaad UB, Gervaix A, Pinosch S, Szucs TD. Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland. Vaccine. 2003;21(23):3273-81. (Pubitemid 36694568)
18. Black S, Lieu TA, Ray GT, Capra A, Shinefield HR. Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente. Vaccine. 2000;19 Suppl 1:S83-6. (Pubitemid 32121726)
19. Claes C, Graf von der Schulenburg JM. Cost effectiveness of pneumococcal vaccination for infants and children with the conjugate vaccine PnC-7 in Germany. Pharmacoeconomics. 2003;21(8):587-600. (Pubitemid 36688102)
20. Kalies K, Hermann M, Schmitt HJ, Kries RV. Pravention invasiver Pneumokokken infektionen im Kindersalter. Welche Impfstrategie ist zu empfehlen. Kinderaerztliche Praxis. 2001;72:90-8.
21. Data on Gender Equality. Employment models in couple households. Swiss Federal Statistical Office 2010. Available at: http://www.bfs.admin.ch/bfs/ portal/en/index/themen/20/05/blank/key/Vereinbarkeit/04.html.
22. Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, et al. Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA. 2000;283(11):1460-8. (Pubitemid 30151825)
23. Atkinson M, Lakhanpaul M, Smyth A, Vyas H, Weston V, Sithole J, et al. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial. Thorax. 2007;62(12):1102-6. PMCID: 2094276. (Pubitemid 350206206)
24. Tsarouhas N, Shaw KN, Hodinka RL, Bell LM. Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia. Pediatr Emerg Care. 1998;14(5):338-41. (Pubitemid 28498709)
25. Hazir T, Fox LM, Nisar YB, Fox MP, Ashraf YP, MacLeod WB, et al. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet. 2008;371(9606):49-56.
26. Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics. 2010;125(1):26-33.
27. Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34(4):434-40. (Pubitemid 34112262)
28. Resti M, Moriondo M, Cortimiglia M, Indolfi G, Canessa C, Becciolini L, et al. Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples. Clin Infect Dis.51(9):1042-9.
29. Smyth AR, Barbato A, Beydon N, Bisgaard H, de Boeck K, Brand P, et al. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J.35(2):247-65.